HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

nicanartine

structure given in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - nicanartine: 3

Related Diseases

1.	Diabetic Retinopathy (Retinopathy, Diabetic) 06/01/1997 - "Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine." 06/01/1997 - "These data indicate that antioxidant therapy with nicanartine is of limited benefit in diabetic retinopathy, at least in the rodent model of streptozotocin-induced diabetes." 06/01/1997 - "In order to study the contribution of oxidant stress to the pathogenesis of experimental diabetic retinopathy, male streptozotocin diabetic Lewis rats were treated with the antioxidant and lipid-lowering compound nicanartine (80 mg/kg; n = 8, blood glucose level 16.7 +/- 3.9 mmol/l; HbA1 11.8 +/- 1.6%) by oral supplementation for 6 months and compared with untreated diabetic (n = 6; blood glucose 18.1 +/- 1.4 mmol/l; HbA1 11.5 +/- 1.5%) and untreated, non-diabetic rats (n = 8; blood glucose 4.0 +/- 0.6 mmol/l; HbA1 4.8 +/- 0.9%). "
2.	Atherosclerosis 10/01/1996 - "Effects of the new antioxidant nicanartine in an experimental model of atherosclerosis."
3.	Body Weight (Weight, Body) 01/01/1998 - "After a break of 7 days, balloon angioplasty was performed in 36 animals, of which 18 received Nicanartine at a dose of 120 mg/kg body weight; the other 18 served as a control group. "

Related Drugs and Biologics

1.	Antioxidants
2.	Oxidants (Oxidizing Agents)
3.	Streptozocin (Streptozotocin)
4.	Lipids
5.	Glycated Hemoglobin (Glycosylated Hemoglobin)
6.	Blood Glucose (Blood Sugar)

Related Therapies and Procedures

1.	Therapeutics